Use of a patch containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase II, randomised, double-blind, placebo-controlled field trial

Cross-Protection by B Subunit-Whole Cell Cholera Vaccine Against Diarrhea Associated with Heat-Labile Toxin-Producing Enterotoxigenic Escherichia coli: Results of a Large-Scale Field Trial

John D. Clemens, David A. Sack, Jeffrey R. Harris et al. · The Journal of Infectious Diseases · 1988 · 343 citations

Veterinary Medicine, Infectious Diseases, Microbiology +17

Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine

Heikki Peltola, A. Siitonen, Matti Kataja et al. · The Lancet · 1991 · 275 citations

Medicine, Infectious Diseases, Preventive Medicine +12

Prevalence of Enteric Pathogens among International Travelers with Diarrhea Acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay)

Zhi‐Dong Jiang, Brett Lowe, M P Verenkar et al. · The Journal of Infectious Diseases · 2002 · 268 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +15

Enteroaggregative<i>Escherichia coli</i>as a Major Etiologic Agent in Traveler's Diarrhea in 3 Regions of the World

Javier A. Adachi, Zhi‐Dong Jiang, John J. Mathewson et al. · Clinical Infectious Diseases · 2001 · 216 citations

Medicine, Infectious Diseases, Pathobiology +17

A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY OF RIFAXIMIN COMPARED WITH PLACEBO AND WITH CIPROFLOXACIN IN THE TREATMENT OF TRAVELERS’ DIARRHEA

David N. Taylor, A. Louis Bourgeois, Charles D. Ericsson et al. · American Journal of Tropical Medicine and Hygiene · 2006 · 150 citations

Pharmacy, Pharmacology, Pharmacotherapy +14